Tissue from the Parkinson’s UK Brain Bank has provided vital clues to why brain cells are lost in Parkinson's
Scientists at the University Bath have improved our understanding of the potentially toxic structures that the protein, alpha-synuclein, can form.
Researchers in Portugal have discovered that the content of dreams, particularly those with negative emotions, may predict long-term cognitive decline in people with Parkinson’s.
An international team of researchers have uncovered a biological link that may account for why those with diabetes have a higher risk of developing Parkinson’s.
Major pharmaceutical company Biogen is investing $1billion to take LRRK2 inhibitors into large scale clinical trials in 2021.
We’re investing a further £1 million to drive forward drugs that target energy-producing mitochondria to slow the loss of brain cells in Parkinson's.
Researchers are taking steps to invite people back to take part in face-to-face studies. To help them make sure their research resumes in a safe, practical, and convenient way, we'd like you to take part in a survey.
Government missed target on recruiting mental health staff. This could impact on people with Parkinson’s
A new report released today (24 July) shows that people with neurological conditions, such as Parkinson’s, struggle to access effective mental health care that meets their needs.
An update on meetings we’ve had this week about social care that raise the concerns of our community.